Drugs / HTD4010
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02538848 | Oct 2015 → Mar 2016 | type 2 diabetes mellitus | HighTide Biopharma Pty Ltd | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HTD4010 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02538848 ↗ |
| Modality | Peptide | “analog of INGAP peptide” NCT02538848 ↗ |